Research Staff Perspectives on Cancer Clinical Trials and Barriers to Recruitment: A Qualitative Research
- PMID: 34540430
- PMCID: PMC8439775
- DOI: 10.7759/cureus.17202
Research Staff Perspectives on Cancer Clinical Trials and Barriers to Recruitment: A Qualitative Research
Abstract
Background Clinical trials are key elements of the processes that account for many of the recent advances in cancer care. Unfortunately, they are becoming more challenging to conduct. Furthermore, a large number of clinical trials in oncology close early due to poor accrual. To identify opportunities for continued improvement in clinical trial enrollment, we sought to identify the obstacles encountered by our clinical trial research staff in these activities. Methods This is a prospective qualitative study, using Grounded Theory Methodology that was concluded at Stephenson Cancer Center (SCC). SCC has been the lead accruer to National Cancer Institute-Lead Academic Participating Sites (NCI-LAPS) trials over the past three years, and in addition, fields investigator-initiated and industry-sponsored trials. We conducted a survey of our research staff including all research nurses and disease site coordinators who participate in recruitment, screening, consenting, data collection, and compliance for interventional clinical trials. We then performed a follow-up meeting with our research coordinators to clarify responses. The study objectives were to highlight common barriers to recruiting adult cancer patients, encountered by research coordinators from all disease sites and to propose effective solutions to identified barriers. Results We are reporting our results of investigating barriers to clinical trials enrollment from a new perspective. The most commonly reported obstacles for clinical trials enrollment from our research staff's perspective were categorized into five themes: clinical trials protocol, communication barriers and cultural beliefs, financial barriers, patients' comorbidities and performance status, and physicians' commitment. Conclusions Although assessing barriers encountered by clinical research staff is an infrequently used metric for improving clinical trial enrollment, it provides an important perspective in the field. Implementing interventions to improve clinical trial feasibility and accrual is critical to improving cancer care.
Keywords: barriers to clinical trials enrollment; cancer clinical trials; interventions to improve clinical trials accrual; quality improvement; research staff perspective.
Copyright © 2021, Keruakous et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.Clin Trials. 2020 Apr;17(2):184-194. doi: 10.1177/1740774520901514. Epub 2020 Feb 3. Clin Trials. 2020. PMID: 32009456 Free PMC article.
-
Provider motivations and barriers to cancer clinical trial screening, referral, and operations: Findings from a survey.Cancer. 2024 Jan 1;130(1):68-76. doi: 10.1002/cncr.35044. Epub 2023 Oct 18. Cancer. 2024. PMID: 37851511
-
Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives.JNCI Cancer Spectr. 2021 Mar 22;5(3):pkab027. doi: 10.1093/jncics/pkab027. eCollection 2021 Jun. JNCI Cancer Spectr. 2021. PMID: 34104866 Free PMC article.
-
Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experience.Trials. 2022 Aug 9;23(1):645. doi: 10.1186/s13063-022-06536-x. Trials. 2022. PMID: 35945621 Free PMC article. Review.
-
Trial-level factors affecting accrual and completion of oncology clinical trials: A systematic review.Contemp Clin Trials Commun. 2021 Oct 21;24:100843. doi: 10.1016/j.conctc.2021.100843. eCollection 2021 Dec. Contemp Clin Trials Commun. 2021. PMID: 34765799 Free PMC article. Review.
Cited by
-
Taxonomy of chronic illness research recruitment: a restricted scoping review.BMC Health Serv Res. 2025 Jul 29;25(1):986. doi: 10.1186/s12913-025-13115-8. BMC Health Serv Res. 2025. PMID: 40731406 Free PMC article.
-
Optimizing Recruitment and Retention in Cancer Clinical Trials in Low-Resource Settings: Barriers and Facilitators From Nigerian Provider's Perspectives.JCO Glob Oncol. 2025 Feb;11:e2400308. doi: 10.1200/GO-24-00308. Epub 2025 Feb 13. JCO Glob Oncol. 2025. PMID: 39946669 Free PMC article.
-
Participation in and withdrawal from cancer clinical trials: A survey of clinical research coordinators.Asia Pac J Oncol Nurs. 2022 Jan 1;9(4):197-201. doi: 10.1016/j.apjon.2021.12.015. eCollection 2022 Apr. Asia Pac J Oncol Nurs. 2022. PMID: 35571627 Free PMC article.
-
The motivation of breast cancer patients to participate in a national randomized control trial.Support Care Cancer. 2023 Jul 15;31(8):468. doi: 10.1007/s00520-023-07930-0. Support Care Cancer. 2023. PMID: 37452876 Free PMC article. Clinical Trial.
-
Research coordinators' perspectives on recruitment of minoritized people with cystic fibrosis into clinical trials.BMC Pulm Med. 2025 Jul 4;25(1):325. doi: 10.1186/s12890-025-03707-9. BMC Pulm Med. 2025. PMID: 40615798 Free PMC article.
References
-
- Barriers to clinical trial accrual: perspectives of community-based providers. Knelson LP, Cukras AR, Savoie J, et al. Clin Breast Cancer. 2020;20:395–401. - PubMed
-
- Clinical trial accrual among new cancer patients at a community-based cancer center. Go RS, Frisby KA, Lee JA, et al. Cancer. 2006;106:426–433. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous